Skip to content
healthcare.dev

Ranolazine

NDC 71610-518, RANOLAZINE, tablet, film coated, extended release, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-518
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212781
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-518 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE500 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
71610-518-42716100518421800 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-518-42)
71610-518-83716100518833600 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-518-83)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/abb32182-46ba-49d2-b2ac-13de2ecf802d

Use it

Look up 71610-518 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-518 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-518. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.